Decreased UCHLI expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors Discussion

被引:0
|
作者
Libutti, Steven K.
Moore, Maureen D.
Keutgen, Xavier
Howe, James R.
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:230 / 231
页数:2
相关论文
共 50 条
  • [1] Decreased UCHLI expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors
    Moore, Maureen D.
    Finnerty, Brendan
    Gray, Katherine D.
    Hoda, Rana
    Liu, Yi-Fan
    Soong, Lauren
    Beninato, Toni
    Rao, Rema
    Zarnegar, Rasa
    Fahey, Thomas J., III
    SURGERY, 2018, 163 (01) : 226 - 230
  • [2] Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors DISCUSSION
    McHenry, Christopher R.
    Cherenfant, Jovenel
    Sarr, Michael G.
    Walsh, R. Matthew
    Ahmad, Syed
    Martin, Robert
    SURGERY, 2013, 154 (04) : 791 - 793
  • [3] Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors
    Cherenfant, Jovenel
    Stocker, Susan J.
    Gage, Mistry K.
    Du, Hongyan
    Thurow, Tiffany A.
    Odeleye, Melanie
    Schimpke, Scott W.
    Kaul, Karen L.
    Hall, Curtis R.
    Lamzabi, Ihab
    Gattuso, Paolo
    Winchester, David J.
    Marsh, Robert W.
    Roggin, Kevin K.
    Bentrem, David J.
    Baker, Marshall S.
    Prinz, Richard A.
    Talamonti, Mark S.
    SURGERY, 2013, 154 (04) : 785 - 791
  • [4] Pancreatic polypeptide as a biomarker for pancreatic neuroendocrine tumors
    Alistar, Angela Tatiana
    Moshier, Erin L.
    Kim, Michelle
    Warner, Richard
    Holcombe, Randall F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Aggressive surgery for metastatic liver neuroendocrine tumors - Discussion
    Fahey, TJ
    Norton
    Thompson, DW
    Snyder, SK
    Pasieka, JL
    Mitchell, B
    Skogseid, B
    SURGERY, 2003, 134 (06) : 1063 - 1065
  • [6] Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable? Discussion
    Rush, Robert M., Jr.
    AMERICAN JOURNAL OF SURGERY, 2007, 193 (05): : 613 - 613
  • [7] Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling
    Tran, Catherine G.
    Scott, Aaron T.
    Li, Guiying
    Sherman, Scott K.
    Ear, Po Hien
    Howe, James R.
    SURGERY, 2021, 169 (01) : 155 - 161
  • [8] Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling
    Tran, C.
    Scott, A.
    Li, G.
    Sherman, S.
    Ear, P. H.
    Howe, J.
    PANCREAS, 2021, 50 (03) : 441 - 441
  • [9] Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling DISCUSSION
    Chen, Herb
    Carr, Jennifer
    Nilubol, Naris
    Rosen, Jennifer
    Olson, John
    SURGERY, 2012, 152 (06) : 1007 - 1007
  • [10] Surgical experience with functioning pancreatic neuroendocrine tumors - Discussion
    Stain, SC
    Matthews, BD
    AMERICAN SURGEON, 2002, 68 (08) : 665 - 666